| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | +3711.3% |
| Cost of Revenue | $16K | -59.2% |
| Gross Profit | $2.2M | — |
| R&D Expense | $48K | -80.5% |
| SG&A Expense | $4.3M | -0.7% |
| Operating Income | -$2.2M | +52.4% |
| Interest Expense | $18K | +0.0% |
| Pre-tax Income | -$2.1M | +52.9% |
| Income Tax | $2K | -93.4% |
| Net Income | -$1.8M | +55.7% |
| EPS (Basic) | -$0.37 | +76.0% |
| EPS (Diluted) | -$0.37 | +76.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $527K | -82.8% |
| Accounts Receivable | $836K | — |
| Current Assets | $1.5M | -58.9% |
| Total Assets | $2.1M | -41.7% |
| Current Liabilities | $143K | +443.1% |
| Total Liabilities | $143K | +443.1% |
| Stockholders' Equity | $10.2M | -10.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | +58.7% |
| Investing Cash Flow | -$609K | — |
| Financing Cash Flow | $3.3M | +0.0% |